VERU INC. Finance Lease, Weighted Average Discount Rate, Percent
VERU INC. (VERU) had Finance Lease, Weighted Average Discount Rate, Percent of 13.90% as of 2021-12-31, per its 10-Q filed 2022-02-09.
Discontinued › Notes › Leases
us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent · last filed 2022-12-05
- 2021-12-31: Finance Lease, Weighted Average Discount Rate, Percent 13.90%.
- 2021-09-30: Finance Lease, Weighted Average Discount Rate, Percent 13.90%.
- 2021-06-30: Finance Lease, Weighted Average Discount Rate, Percent 13.90%.
- 2021-03-31: Finance Lease, Weighted Average Discount Rate, Percent 13.90%.
| Period end | Finance Lease, Weighted Average Discount Rate, Percent |
|---|---|
| 2021-12-31 | 13.90% 10-Q · filed 2022-02-09 |
| 2021-09-30 | 13.90% 10-K · filed 2022-12-05 |
| 2021-06-30 | 13.90% 10-Q · filed 2021-08-12 |
| 2021-03-31 | 13.90% 10-Q · filed 2021-05-12 |
| 2020-12-31 | 13.90% 10-Q · filed 2021-02-10 |
| 2020-09-30 | 13.90% 10-K · filed 2021-12-02 |
| 2020-06-30 | 13.86% 10-Q · filed 2020-08-13 |
| 2020-03-31 | 13.86% 10-Q · filed 2020-05-13 |
| 2019-12-31 | 13.86% 10-Q · filed 2020-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |